A proprietary speech analysis app can discern vocal variations that reflect changes in lung fluid status that one day, researchers hope, might provide early warning of acute decompensation.
/PRNewswire/ Inhibrx, Inc. (Nasdaq: INBX), announced the appointment of three key executives: David Matly, M.B.A., as Chief Commercial Officer; David Kao,.